AllDocs -> cancers

a a l l l l I I r r e e l l a a n n d d c c a a n n c c e e r r s s t t a a t t i i s s t t i i c c s s s s e e c c o o n n d d r r e e p p o o r r t t 1 1 9 9 9 9 8 8 - - 2 2 0 0 0 0 0 0 34 Lung cancer Lung cancer Lung cancer Lung c ancer Lung cancer Lung cancer Lung cancer L ung cancer Lung cancer Lung cancer Lung can cer Lung cancer Lung cancer Lung cancer Lun g cancer Lung cancer Lung cancer Lung cance r Lung cancer Lung cancer Lung cancer Lung cancer Lung cancer Lung cancer Lung cancer Lung cancer Lung cancer Lung cancer Lung c ancer Lung cancer Lung cancer Lung cancer L ung cancer Lung cancer Lung cancer Lung can cer Lung cancer Lung cancer Lung cancer Lun g cancer Lung cancer Lung cancer Lung cance r Lung cancer Lung cancer ...

63 Lung Cancer 11 11.1. INTRODUCTION AND SUMMARY Lung cancer incidence and mortality were almost the same, with an overall mortality/incidence ratio of 91.3% or a survival of only 8.7% (Table 11.1). For the first time since registration of lung cancers began, the number of cases exceeded that of deaths. This may reflect more accurate certification of deaths or the continuing decline in lung cancer mortality. Incidence in males shows a definite downward trend of almost 5% per year. Female rates have increased by 0.4% per year since 1994, but this trend is not statistically significant. Table 11.1. Summary of incidence and mortality statistics: lung cancer INCIDENT CASES DEATHS males females both sexes males females both sexes All cancers (invasive, in situ and uncertain) (ICD-O-2 C34) 1997 cases 909 ...

System Analysis in Evaluating the Contribution of Indoor Radon to Lung Cancer Vladimir L. Lezhnin, Eugene V. Polzik, Vladimir S. Kazantsev, Ilia V. Yarmoshenko Institute of Industrial Ecology, UB RAS, 20a, Sofia Kovalevskaya Street, GSP-594, Yekaterinburg 620219, Russia Tel/Fax +7 343 374-37-71, e-mail: Lezhnin@ecko.uran.ru In 1987 experts of the International Agency for Research on Cancer reached the conclusion that radon and its decay products are carcinogenic to humans. Such a conclusion was made based on epidemiologic studies of uranium miners occupationally exposed to high levels of radon. Although the extrapolation of those results to the range of low doses usually found in dwellings had many uncertainties, radon and its progeny were thought to be the cause of the majority of lung cancer cases. As a result, many countries and international organizations developed recommendations and regulations ...

research for a cure laboratory without walls National Foundation for Cancer Research Cancer FAQs about lung cancer Frequently Asked Questions about common cancers. Page 2 Page 3 About Lung Cancer A Good Reason to Quit Smoking is responsible for the largest number of premature deaths in the United States. According to the Centers for Disease Control, smoking claims the lives of 430,000 adults in the U.S. each year.Your risk of developing lung cancer is 10 times greater if you smoke. In addition, researchers are finding that smoking also may contribute to other types of cancer , including cancer of the larynx, oral cavity, esophagus, urinary bladder, kidney, pancreas, stomach and uterine cervix. There are many tools available to help smokers quit. The nicotine patch, gum and nasal ...

FOR IMMEDIATE RELEASE Contact: Michelle Pollak The Wellness Community (202) 659-9709 michelle@thewellnesscommunity.org NEW INFORMATION ABOUT SMALL CELL LUNG CANCER WASHINGTON, D.C. – April 13, 2004 – A new resource about small cell lung cancer (SCLC) is now available free of charge from The Wellness Community® (TWC), an international, non-profit dedicated to providing free support and education to people affected by any type of cancer . A booklet entitled, Frankly Speaking About Lung Cancer : A Special Focus on Small Cell Lung Cancer offers key steps for a better understanding of SCLC so that people may maximize treatment options and make educated decisions about therapy. It also provides information on proactively managing side effects, including the emotional impact of cancer . The booklet incorporates the philosophy of The Wellness Community’s Patient ...

FOR IMMEDIATE RELEASE Contact: Michelle Pollak The Wellness Community (202) 659-9709 michelle@thewellnesscommunity.org NEW INFORMATION ABOUT SMALL CELL LUNG CANCER WASHINGTON, D.C. – April 13, 2005 – A new resource about small cell lung cancer (SCLC) is now available free of charge from The Wellness Community® (TWC), an international, non-profit dedicated to providing free support and education to people affected by any type of cancer . A booklet entitled, Frankly Speaking About Lung Cancer : A Special Focus on Small Cell Lung Cancer offers key steps for a better understanding of SCLC so that people may maximize treatment options and make educated decisions about therapy. It also provides information on proactively managing side effects, including the emotional impact of cancer . The booklet incorporates the philosophy of The Wellness Community’s Patient ...

Mayo Clin Proc, September 2003, Vol 78 CT Screening for Lung Cancer 1187 Mayo Clin Proc . 2003;78:1187-1188 1187 © 2003 Mayo Foundation for Medical Education and Research Commentary Computed Tomographic Screening for Lung Cancer : Home Run or Foul Ball? S TEPHEN J. S WENSEN , MD; J AMES R. J ETT , MD; D AVID E. M IDTHUN , MD; AND T HOMAS E. H ARTMAN , MD From the Department of Radiology (S.J.S., T.E.H.) and Division of Pulmonary and Critical Care Medicine and Internal Medicine (J.R.J., D.E.M.), Mayo Clinic, Rochester, Minn. This commentary was funded in part by the National Cancer Institute (RO1 CA 79935-03). Individual reprints of this article are not available. Address corre- ...

Patient's Guide to Thoracic Cancer The Thoracic Oncology Program consists of an experienced team of nationally recognized cancer specialists experienced in the treatment of: • Lung Cancer • Tracheal Cancer • Esophageal Cancer • Mesothelioma • Thymomas • Other Mediastinal Tumors • Chest Wall Tumors Lung Cancer Introduction Lung cancer is one of the most common malignant tumors worldwide. Until recently, the detection of lung cancer occurred in its most advanced stages. But a new screening technique with low dose CT scanning is making it possible to detect lung cancer in its earliest stages, when it is most treatable. There are several known risk factors for lung cancer , including: Cigarette smoking-Smokers have a significantly higher risk of developing lung cancer than nonsmokers. Passive smoke- Nonsmokers ...

1 Contact: Emily Oehler 703-460-5572 Diane Shnitzler 703-460-5582 From 3/30-4/5 call 504-670-5209 On 3/29 call Martin Blair 212-453-2349 Embargoed for Release, Saturday, April 2, 2005, 8:00 a.m. CT Prospective, Multicenter Lung Cancer Trial Shows Heat Directly Kills Tumors In 93 Percent of Cases Interventional Radiology Study Also Shows Nonsurgical Technique Offers a 91 Percent Cancer -Specific Survival Rate at Two Years NEW ORLEANS, Louisiana (April 2, 2005) – After receiving treatment of radiofrequency heat to “cook” and kill their lung tumors, patients had a 91 percent cancer -specific survival rate at one and two years, according to results of a prospective, multicenter trial that was presented today at the Society of Interventional Radiology's 30th Annual Scientific Meeting. The research also showed the radiofrequency ablation (RFA) technique ...

37 Lung Cancer General Information San Diego County The age-adjusted incidence rate of lung cancer in San Diego County in 2000 was 62.3 per 100,000 population. California 3 The age-adjusted incidence rate of lung cancer in California from 1996-2000 was 76.5 per 100,000 male popula- tion and 50.4 per 100,000 female population. National 3 The age-adjusted incidence rate of lung cancer in the U.S. from 1996-2000 was 91.5 per 100,000 male population and 53.4 per 100,000 female population. In 2004 there will be about 173,770 new cases of lung cancer in the United States: 93,110 among men and 80,660 among women. High-risk Populations 1 The following populations have a higher risk for developing lung cancer than the general population: • Smokers and persons living with smokers—The longer a person smokes or is exposed to tobacco ...

NC OFFICE • BATTELLE • CENTERS FOR PUBLIC HEALTH RESEARCH & EVALUATION 100 CAPITOLA DR, SUITE 301 • DURHAM, NC 27713 • 1-800-4AG-STUDY Lung Cancer Spring 2005 Lung Cancer Lung cancer is one of the most frequently diagnosed cancers in the world and is the leading cause of cancer death. Are participants in the Agricultural Health Study at increased risk for lung cancer ? Based on the current findings from the study, participants are significantly less likely – over 50% less likely – than other people in North Carolina and Iowa to be diagnosed with lung cancer . This is very good news for the farm population. Why do farmers, overall, have less lung cancer than the general population? There may be several reasons, but the main one is that farmers and their spouses smoke less than non-farmers. Overall, 14% ...

QUESTIONS & ANSWERS ABOUT LUNG CANCER Q: What are the early signs of lung cancer ? How would I know I have it? A: Some of the early warning signs of lung cancer are: • A cough that doesn’t go away • Chest pain • Hoarseness • Weight loss and loss of appetite • Bloody or rust-colored sputum • Shortness of breath • Fever without a known reason • Recurring infections such as bronchitis or pneumonia These symptoms can also come from other diseases, so seeing your health care provider is the only way to find out what may be causing these symptoms. Q: How is lung cancer diagnosed? A: Your doctor may do one or more of the following procedures to ...

Residential radon and lung cancer NEZAHAT HUNTER • NATIONAL RADIOLOGICAL PROTECTION BOARD • CHILTON In most of the world, the major risk factor for lung cancer is tobacco consumption. Occupational radon and asbestos exposure are other important factors but affect specific groups only. While studies of underground miners have shown that lung cancer is induced in humans by exposure to radon and its decay products, the evidence of health effects from studies of indoor radon exposure is less certain. To address this problem, a European pooled study is being performed to resolve the lung cancer risk from indoor radon to the public. his article summarises a workshop held in Oxford, during April 2000, by a European collaborative group that is examining the lung cancer risk associated with residential radon exposure. The workshop also served as the contractors meeting for an associated ...

Lung Cancer Pathogenesis After HZE Particle Exposure Jerry W. Shay 1 , Michael D. Story 2 , David J. Chen 2 , Adi F. Gazdar 3 , and John D. Minna 3 The University of Texas Southwestern Medical Center NSCOR 1 Department of Cell Biology, 2 Department of Radiation Oncology, 3 Hamon Center for Therapeutic Oncology Research Dallas, Texas 75390 The University of Texas Southwestern Medical Center (UTSW) NSCOR focuses on the development of quantitative dose risk estimates following HZE particle irradiation for the development of key genetic, epigenetic, gene expression, and cellular functional changes in the multistep pathogenesis of lung cancer in both new human bronchial epithelial cell (HBEC) and transgenic mouse models of lung cancer . The risk of developing these changes will also be ...

2 N ORTHERN C ALIFORNIA C ANCER C ENTER , Cancer Incidence and Mortality in the Greater Bay Area • Lung cancer incidence and mortality rates have declined during the 15-year period across all racial/ethnic groups, particularly for males. In 2002, black males had the highest rate of lung cancer incidence, while Hispanics and Asians/Pacific Islanders had the lowest. • Colorectal cancer incidence and mortality rates have decreased slightly during the period 1988- 2002 for all racial/ethnic groups. Incidence rates were slightly higher in males than females and did not differ markedly by race/ethnicity. • Incidence rates for invasive melanoma have been fairly stable, while rates of in situ melanoma increased, but stabilized after 1996. Increases in the in situ form of this cancer may be due to increased ...

Clinical Guideline 24 February 2005 Developed by the National Collaborating Centre for Acute Care Lung cancer The diagnosis and treatment of lung cancer Page 2 Clinical Guideline 24 Lung cancer : the diagnosis and treatment of lung cancer Issue date: February 2005 This document, which contains the Institute's full guidance on lung cancer , is available from the NICE website (www.nice.org.uk/CG024NICEguideline). An abridged version of this guidance (a 'quick reference guide') is also available from the NICE website (www.nice.org.uk/CG024quickrefguide). Printed copies of the quick reference guide can be obtained from the NHS Response Line: telephone 0870 1555 455 and quote reference number N0825. The distribution list for the quick reference guide can be found at www.nice.org.uk/CG024distributionlist Information ...

The diagnosis and treatment of lung cancer Understanding NICE guidance – information for people with lung cancer , their families and carers, and the public February 2005 Information about NICE Clinical Guideline 24 Page 2 National Institute for Clinical Excellence MidCity Place 71 High Holborn London WC1V 6NA www.nice.org.uk ISBN: 1-84257-894-4 Published by the National Institute for Clinical Excellence February 2005 Printed by Abba Litho (Sales) Ltd © National Institute for Clinical Excellence, February 2005. All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes within the NHS. No reproduction by or for commercial organisations is allowed without the express written permission of the National Institute for Clinical Excellence. The diagnosis ...

L UNG AND B REAST C ANCER D EATHS A MONG A RIZONA F EMALES , 1970-1999 Tim Flood, MD, Medical Director, and Amy C. Stoll, MS, Epidemiologist Bureau of Public Health Statistics, Arizona Department of Health Services SUMMARY For the past 17 years, the number of women dying of lung cancer in Arizona has surpassed the number dying of breast cancer . In 1999, deaths from lung cancer for Arizona women totaled 1102 and deaths from breast cancer totaled 657. There was a steady increase in female lung cancer death rates between 1970 to 1987, and then the rate stabilized at around 29 deaths per 100,000 women for the past 12 years (1988 to 1999). Breast cancer mortality rates have decreased since 1970, with an impressive 17% decline noted over the ...

Palda & Van Spall with CTF – Lung Cancer Screening Screening for Lung Cancer : Updated Recommendations from the Canadian Task Force on Preventive Health Care 1 Valerie A. Palda, MD, MSc and 2 Harriette G.C. Van Spall, M.D, BSc with 3 Canadian Task Force on Preventive Health Care 1 Assistant Professor, General Internal Medicine Victoria 4-151, St. Michael’s Hospital 30 Bond Street Toronto, Ontario M5B 1W8 2 Postgraduate Year 2 Trainee, Internal Medicine University of Toronto 190 Elizabeth Street R. Fraser Elliott Building 3-805 Toronto, Ontario M5G 2C4 3 117-100 Collip Circle London, Ontario N6G 4X8 Tel: 519-858-5181 Fax: 519-858-5112 (address for correspondence) August 2003 Running Head: Palda & Van Spall with CTF – Lung Cancer Screening ...

Cigarette Smoking and Lung Cancer * A Disease Detectives Exercise from the Centers for Disease Control and Prevention PART 1 (Time to completion: 10 minutes) In the 1920s, health care workers in Great Britain first began to suspect a relationship between cigarette smoking and lung cancer . The suspicion was based on the fact that many patients who acquired lung cancer were also smokers. Although this was an astute observation, these workers lacked the scientific evidence to justify their position. As a result, between 1930 and 1960, numerous epidemiologic studies were undertaken to try to quantify the relationship between cigarette smoking and lung cancer . Two of these studies, one in 1947 by Sir Richard Doll and one in 1951 by A.B. Hill, are considered classics. Doll used the case-control study method and compared the smoking history of a group of hospitalized ...

Cigarette Smoking and Lung Cancer * A Disease Detectives Exercise from the Centers for Disease Control and Prevention Teacher’s Guide and Answer Key Instructions • Prepare students by teaching the fundamental principles of epidemiology and outbreak investigation. Materials are available on the EXCITE web site in “Background and Teaching Aids.” At a minimum, students should be familiar with the basic steps of an outbreak investigation. • One recommended format is to divide the class into small work groups of 5-10 students and have each group assign a facilitator, a recorder, and a reporter. Ask individual students from the class at large to read the narrative and questions out loud. Then have students work in their small groups to answer the questions. Finally, have the groups report their responses to the class. • The exercise is in eleven parts. Each part should be distributed ...

PUBLIC HEALTH FACT SHEET Lung Cancer What is Lung Cancer ? Lung cancer typically begins as a tiny spot on the inner lining of a bronchial tube. It can take many years for lung cancer to develop and be discovered. Lung cancer is the leading cause of cancer deaths for both men and women. What are the Symptoms of Lung Cancer ? • Constant chest pain • Persistent cough • Blood in saliva • Wheezing • Shortness of breath during routine activities • Hoarseness • Fever • Neck enlargement • Weight loss • Arm and shoulder pain • Repeated pneumonia and bronchitis What are the Risk Factors for Lung Cancer ? • Smoking • Second hand smoke • Air pollution • Occupational exposure to hazardous agents, such as asbestos • Scarred area from a previous inflammation • Exposure to asbestos • Exposure to radon ...

Chemotherapy in Non-Small Cell Lung Cancer : An Update A meta-analysis of randomised trials using individual patient data Protocol C Comparison 3 Surgery + Radiotherapy vs Surgery +Radiotherapy + Adjuvant Chemotherapy Conducted by the Non-Small Cell Lung Cancer Collaborative Group (NSCLCCG) May 2004 Page 2 Protocol C surgery + radiotherapy vs surgery + radiotherapy + chemotherapy NSCLC Collaborative Group Secretariat Comparisons 1, 2 & 7 please contact Meta-analysis Group MRC Clinical Trials Unit 222 Euston Road London NW1 2DA UK Fax: +44 (0)20 7670 4816 Sarah Burdett email: sb@ctu.mrc.ac.uk tel: +44 (0)20 7670 4722 Lesley Stewart email: ls@ctu.mrc.ac.uk tel: +44 (0)20 7670 4724 Richard Stephens email: ...

providing research and information services to the Scottish Parliament 1 Research Note 00/95 13 November 2000 LUNG CANCER AND ASBESTOS (MESOTHELIOMA) This note provides background information on S1M-1273, for debate on 16 November 2000, on compensation for mesothelioma sufferers. THE ISSUE S1M-1273 reads: 'that the Parliament notes the plight of shipyard workers and their families who were exposed to asbestos, became ill and have now contracted mesothelioma; expresses concern over the length of time their compensation cases are taking to reach conclusion and the use of so-called "blanket denials" by the defenders, and notes that this practice victimises and denies justice to these cancer sufferers.' 1 Sufferers have in mind to persuade the Parliament to precipitate a change in the law that will allow compensation claims to proceed more quickly ...

Principal Investigator/Program Director (Last, first, middle): Hersh, Louis B. PHS 398 (Rev. 05/01) Form Page 2 Page 156 Project 3 Talin-1: A Metastasis Suppressor in Lung Cancer . Richard McCann, Ph.D. Tom Vanaman Ph.D., Mentor Sydney Whiteheart, Ph.D. co- Mentor No human subjects or human subject materials involved in this project. No Vertebrate animals will be used in this project. Page 2 Principal Investigator/Program Director (Last, first, middle): Hersh, Louis B. PHS 398 (Rev. 05/01) Form Page 2 Page 157 DESCRIPTION: State the application’s broad, long-term objectives and specific aims, making reference to the health relatedness of the project. Describe concisely the research design and methods for achieving these goals. Avoid summaries of past accomplishments and the ...

Ÿ Neuroanatomy, 2002, Volume1, Pages 26-28. Case Report Non-small cell lung cancer presenting as a bilateral metastatic brachial plexopathy Necdet Karli (1) Kader Karli Oguz (2) Mehmet Zarifoglu (1) Nebahat Bilici (1) Ozgur Cakir (3) (1) Department of Neurology, University of Uludag, School of Medicine, Gorukle, Bursa, Turkey. (2) Department of Radiology, Hacettepe University, School of Medicine, Sihhiye, Ankara, Turkey. (3) Department of Radiology, University of Uludag, School of Medicine, Gorukle, Bursa, Turkey Correspondence Address Kader Karli Oguz, MD. Hacettepe University, School of Medicine Dept of Radiology 06100 Sihhiye Ankara Turkey Telephone: +90-312 3051188 Fax: +90-312 3112145 E-mail: karlioguz@yahoo.com Received 2 December 2002; accepted 13 December 2002 Abstract Squamous cell carcinoma may present ...

Eastern Journal of Medicine 5 (2): 48-51, 2000 Uzun et al. 48 Objective: It is a known fact that free radicals and lipid peroxidation play a role in lung cancer pathophysiol- ogy. Malondialdehyde (MDA) is an end-product of lipid peroxidation. We studied the value of serum MDA as a possible diagnostic marker for lung cancer . The se- rum MDA levels of 33 patients with malignant lung dis- eases were compared with those of 75 patients with benign lung diseases and 29 healthy subjects. The mean age of patients was 52±18 (male:73, female:35). The mean serum MDA levels in patients with malig- nant and benign lung diseases were found as 4.48±3.19 nmol/ml and 3.08±1.63 nmol/ml, respectively. The mean MDA level of control group was 1.36±0.72 nmol/ml, which was lower than that of benign and malignant lung disease groups (p<0.001, p<0.001). Serum ...

Advocacy The Roy Castle Lung Cancer Foundation: Offering hope By Jesme Baird MB ChB, MBA, Director of Patient Care, The Roy Castle Lung Cancer Foundation, glasgows@roycastle.liv.ac.uk T he Roy Castle Lung Cancer Foundation owes its origin to the British entertainer and celebrity Roy Castle, who decided to lend his name to a lung cancer charity in 1994, after he himself was diagnosed with the dis- ease. A lifelong non-smoker, he adopted a pos- itive attitude to his situation and courageously gave the last year of his life to promoting the work of the charity and to raising funds for lung cancer work. The Foundation that took his name is one of only two charities in the world focused specif- ically on lung cancer . It is committed to work- ing to reduce the incidence of lung cancer and to improving the quality and ...